Literature DB >> 31097089

The role of radiation treatment in pleural mesothelioma: Highlights of the 14th International Conference of the International mesothelioma interest group.

Robert M MacRae1, Miranda Ashton2, Olivia Lauk3, Wesley Wilson4, Noelle O'Rourke2, Charles B Simone5, Andreas Rimner6.   

Abstract

Radiation remains an important component of mesothelioma treatment in 2018. Its use as a treatment modality continues to evolve as the technology for planning and delivery continues to improve. Use of radiation to improve local control in the involved hemithorax has been a common adjuvant treatment post extrapleural pneumonectomy for many years. Modern treatment options with advanced planning techniques including protons and intensity modulated radiation therapy lead to new potential options for treatment post lung-sparing surgery or in the unresectable setting. Presentations and discussions on the implementation of these strategies for palliation, treatment of oligometastatic recurrence or unresectable disease were the focus of a session dedicated to the role of radiation therapy at the 14th International Conference of the International Mesothelioma Interest Group and are reviewed in this article. Preclinical data to better understand how to integrate radiation and the delivery of novel systemic therapy approached like check point inhibitors are also presented.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mesothelioma; Palliation; Radiation; Radiotherapy

Mesh:

Year:  2019        PMID: 31097089     DOI: 10.1016/j.lungcan.2019.03.023

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  1 in total

1.  The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells in vitro and in vivo.

Authors:  Walter Blum; Thomas Henzi; László Pecze; Kim-Long Diep; Christian G Bochet; Beat Schwaller
Journal:  Oncotarget       Date:  2019-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.